These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12909303)

  • 21. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 in the cerebrospinal fluid of newborn with meningitis.
    Krebs VL; Okay TS; Okay Y; Vaz FA
    Arq Neuropsiquiatr; 2005 Mar; 63(1):7-13. PubMed ID: 15830057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concentration of proinflammatory cytokines (TNF-alpha, IL-8) in the cerebrospinal fluid and the course of bacterial meningitis].
    Bociaga-Jasik M; Garlicki A; Kalinowska-Nowak A; Mach T
    Przegl Lek; 2004; 61(2):78-85. PubMed ID: 15230146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis.
    Sharief MK; Thompson EJ
    J Neuroimmunol; 1992 May; 38(1-2):27-33. PubMed ID: 1577950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
    Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
    Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function.
    Csuka E; Morganti-Kossmann MC; Lenzlinger PM; Joller H; Trentz O; Kossmann T
    J Neuroimmunol; 1999 Nov; 101(2):211-21. PubMed ID: 10580806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical central inflammation is risk for RIS and CIS conversion to MS.
    Rossi S; Motta C; Studer V; Macchiarulo G; Germani G; Finardi A; Furlan R; Martino G; Centonze D
    Mult Scler; 2015 Oct; 21(11):1443-52. PubMed ID: 25583841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
    Dellalibera-Joviliano R; Dos Reis ML; Cunha Fde Q; Donadi EA
    J Rheumatol; 2003 Mar; 30(3):485-92. PubMed ID: 12610806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
    Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
    Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with central nervous system infections.
    Tsai ML; Chen WC; Wang YC; Hung KL
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):16-21. PubMed ID: 8936005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients.
    López-Cortés LF; Marquez-Arbizu R; Jimenez-Jimenez LM; Jimenez-Mejías E; Caballero-Granado FJ; Rey-Romero C; Polaina M; Pachón J
    Crit Care Med; 2000 Jan; 28(1):215-9. PubMed ID: 10667525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
    Bartosik-Psujek H; Archelos JJ
    J Neurol; 2004 Apr; 251(4):414-20. PubMed ID: 15083285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
    Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
    J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein profile of cerebrospinal fluid in multiple sclerosis with special reference to the function of the blood brain barrier.
    Eickhoff K; Wikström J; Poser S; Bauer H
    J Neurol; 1977 Feb; 214(3):207-15. PubMed ID: 65455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
    Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
    Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS.
    Puthenparampil M; Tomas-Ojer P; Hornemann T; Lutterotti A; Jelcic I; Ziegler M; Hülsmeier AJ; Cruciani C; Faigle W; Martin R; Sospedra M
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33649179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple sclerosis: clinical and laboratorial correlation].
    Puccioni-Sohler M; Lavrado FP; Bastos RR; Brandão CO; Papaiz-Alvarenga R
    Arq Neuropsiquiatr; 2001 Mar; 59(1):89-91. PubMed ID: 11299438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.